Correction to: Nivolumab versus placebo as adjuvant therapy for resected stage III melanoma: a propensity weighted indirect treatment comparison and number needed to treat analysis for recurrence-free survival and overall survival.
Jeffrey S WeberTayla PorettaBrian D StwalleyLeon A SakkalElla X DuTravis WangYan ChenYan WangKeith A BettsAlexander N ShoushtariPublished in: Cancer immunology, immunotherapy : CII (2022)